Actively Recruiting
Non-invasive Diffusion-weighted Imaging With MRCP in the Diagnosis of Neoplastic Biliary Obstruction
Led by The General Authority for Teaching Hospitals and Institutes · Updated on 2025-08-07
100
Participants Needed
1
Research Sites
30 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This study aims to evaluate the diagnostic value of non-invasive diffusion-weighted magnetic resonance imaging (DW-MRI) in detecting neoplastic biliary obstruction.
CONDITIONS
Official Title
Non-invasive Diffusion-weighted Imaging With MRCP in the Diagnosis of Neoplastic Biliary Obstruction
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adult patients (≥18 years) with clinically suspected biliary obstruction (e.g., jaundice, elevated liver enzymes, cholestasis)
- Patients scheduled for magnetic resonance cholangiopancreatography (MRCP) who have undergone conventional imaging (ultrasound or computed tomography)
- Patients who will undergo further invasive procedures such as endoscopic retrograde cholangiopancreatography (ERCP) or biopsy
You will not qualify if you...
- Patients with contraindications to magnetic resonance imaging (MRI), such as pacemakers or metal implants
- Patients who have previously undergone major biliary surgery or stent placement
- Pregnant or lactating women
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
General Authority for Teaching Hospitals and Institutes
Cairo, Egypt
Actively Recruiting
Research Team
H
Hekmat S Baumey, MD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here